BeStock  
Stocks › Biotechnology › INVA

Innoviva INVA

US equityMarket cap rank #2978Biotechnology
$18.41 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.41 0.00%
Open$18.41
Prev close$18.41
Day range$18.33 – $18.79
Volume1.15M
Market cap$1.31B
P/E (TTM)7.8
Dividend yield–

Earnings

Average move on report day±6.0%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+22.0%
Worst reaction-14.7%

Stock move on the day after each report

+0.0%2015/Q1-8.7%2015/Q2-14.7%2015/Q3+22.0%2015/Q4-0.1%2016/Q1+10.0%2016/Q2-0.4%2016/Q3+0.3%2016/Q4-6.4%2017/Q1+3.7%2017/Q2+4.3%2017/Q3+11.7%2017/Q4
QuarterReport dateTimingImplied moveActual moveVersus implied
2017/Q48 Feb 2018After Market–+11.74%–
2017/Q325 Oct 2017After Market–+4.35%–
2017/Q226 Jul 2017After Market–+3.71%–
2017/Q127 Apr 2017After Market–-6.39%–
2016/Q49 Feb 2017After Market–+0.27%–
2016/Q327 Oct 2016None–-0.41%–
2016/Q228 Jul 2016None–+10.00%–
2016/Q128 Apr 2016After Market–-0.08%–
2015/Q43 Feb 2016After Market–+21.98%–
2015/Q311 Jan 2016After Market–-14.68%–
2015/Q229 Jul 2015None–-8.71%–
2015/Q16 May 2015None–+0.00%–
2014/Q418 Feb 2015After Market–+10.27%–
2014/Q330 Oct 2014After Market–-1.17%–
2014/Q26 Aug 2014After Market–+1.48%–
2014/Q16 May 2014None–-0.22%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Royalty revenue$54.66M 51.5%
  • GIAPREZA$23.23M 21.9%
  • XACDURO$22.00M 20.7%
  • XERAVA$3.59M 3.4%
  • License and other revenue$2.02M 1.9%
  • ZEVTERA$624,000.00 0.6%

Latest reported quarter: Q3, ended Sep 2026

Revenue$106.12M-1.6% YoY
Operating profit$42.15M+21.9% YoY
Net profit-$73.89M-182.2% YoY
Diluted EPS-$1.03-195.4% YoY
Free cash flow$41.67M+6.2% YoY
Operating cash flow$41.70M

Revenue, last 8 quarters

$91.8MDec '24$88.6MMar '25$100.3MJun '25$107.8MSep '25$114.6MDec '25$98.0MMar '26$119.6MJun '26$106.1MSep '26

Net profit, last 8 quarters

$20.3MDec '24$-46.6MMar '25$63.7MJun '25$89.9MSep '25$164.2MDec '25$186.6MMar '26$-83.4MJun '26$-73.9MSep '26

Profitability & balance sheet

Gross margin80.5%
Operating margin38.8%
Net margin44.1%
Return on equity18.0%
Return on assets13.0%
Return on invested capital13.8%
Current ratio15.44
Liabilities / assets26.0%
Cash & investments$590.06M
Total debt$269.11M
Net cash (debt)$320.95M
Free cash flow / sales41.6%

Discussion

No comments yet — be the first to weigh in on INVA.

Sign in to join the discussion.

Scroll to Top